Effect of imatinib mesylate (IM) on endothelial cells (EC) functions

被引：1
|
作者：
Venalis, P. [1 ,2 ,3 ]
Distler, O. [4 ,5 ]
Akhmetshina, A. [1 ,2 ]
Dees, C. [1 ,2 ]
Buch, N. [1 ,2 ]
Gay, S. [4 ,5 ]
Schett, G. [1 ,2 ]
Distler, J. H. W. [1 ,2 ]
机构：
[1] Univ Erlangen Nurnberg, Dept Internal Med 3, D-8520 Erlangen, Germany
[2] Univ Erlangen Nurnberg, Inst Clin Immunol, D-8520 Erlangen, Germany
[3] Vilnius Univ, Fac Med, Ctr Rheumatol, Vilnius, Lithuania
[4] Univ Zurich Hosp, Ctr Expt Rheumatol, CH-8091 Zurich, Switzerland
[5] Univ Zurich Hosp, Zurich Ctr Integrat Human Physiol, CH-8091 Zurich, Switzerland
来源：
JOINT BONE SPINE | 2008年 / 75卷 / 02期
关键词：
D O I：
10.1016/j.jbspin.2008.01.018
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB16
引用
下载
收藏
页码：248 / 248
页数：1
相关论文
共 50 条
  • [21] Secondary leukemia after imatinib mesylate (IM) therapy for chronic myelogenous leukemia (CML).
    Kovitz, CA
    Kantarjian, HM
    Garcia-Manero, G
    Abruzzo, LV
    Cortes, JE
    BLOOD, 2005, 106 (11) : 295B - 295B
  • [22] Evaluation of imatinib mesylate (IM) in patients with large volume gastrointestinal stromal tumors (GISTs)
    Byrd, D. M.
    Demetri, G. D.
    Joensuu, H.
    von Mehren, M.
    Heinrich, M.
    Eisenberg, B.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [23] The effect of type VIII collagen on endothelial cells (EC) in vitro
    Smith, J
    Rooney, P
    Ponting, J
    Macro, J
    Kumar, S
    JOURNAL OF VASCULAR RESEARCH, 1998, 35 (05) : 387 - 387
  • [24] In vivo effects of imatinib mesylate on human haematopoietic progenitor cells
    Agis, H
    Jaeger, E
    Doninger, B
    Sillaber, C
    Marosi, C
    Drach, J
    Schwarzinger, I
    Valent, P
    Oehler, L
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2006, 36 (06) : 402 - 408
  • [25] Retinoic Acid Enhances Sensitivity of Neuroblastoma Cells for Imatinib Mesylate
    Neumann, Ingo
    Foell, Juergen L.
    Bremer, Marianne
    Volkmer, Ines
    Korholz, Dieter
    Burdach, Stefan
    Staege, Martin S.
    PEDIATRIC BLOOD & CANCER, 2010, 55 (03) : 464 - 470
  • [26] Imatinib mesylate decreases the cytotoxic effect of roscovitine on human glioblastoma cells in vitro and the role of midkine
    Erguven, Mine
    Bilir, Ayhan
    Yazihan, Nuray
    Korkmaz, Seval
    Aktas, Esin
    Ovalioglu, Cem
    Dundar, Tolga
    Seyithanoglu, Hakan
    ONCOLOGY LETTERS, 2012, 3 (01) : 200 - 208
  • [27] Combined treatment of 3-hydroxyflavone and imatinib mesylate increases apoptotic cell death of imatinib mesylate- resistant leukemia cells
    Kim, Jung-Hyun
    Song, Minjung
    Kang, Geun-Ho
    Lee, Eung-Ryoung
    Choi, Hye-Yeon
    Lee, Chung
    Kim, Jin-Hoi
    Kim, Youngsoo
    Koo, Bon-Nyeo
    Cho, Ssang-Goo
    LEUKEMIA RESEARCH, 2012, 36 (09) : 1157 - 1164
  • [28] The effect of imatinib mesylate on the contractility of isolated rabbit myometrial strips
    Hutchings, G.
    Deprest, J.
    Nilius, B.
    Roskams, T.
    De Ridder, D.
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2006, 62 (02) : 79 - 83
  • [29] Drug responses of imatinib mesylate-resistant cells: synergism of imatinib with other chemotherapeutic drugs
    Tipping, AJ
    Mahon, FX
    Zafirides, G
    Lagarde, V
    Goldman, JM
    Melo, JV
    LEUKEMIA, 2002, 16 (12) : 2349 - 2357
  • [30] Drug responses of imatinib mesylate-resistant cells: synergism of imatinib with other chemotherapeutic drugs
    AJ Tipping
    FX Mahon
    G Zafirides
    V Lagarde
    JM Goldman
    JV Melo
    Leukemia, 2002, 16 : 2349 - 2357
12345